Table 1.

Effect of Cassia fistula methanolic extract (CFME) on serum biomarkers after ISP-induced myocardial necrosis.

Groups	Triglycerides (TG) (mg/dl)		Total cholesterol (TC) (mg/dl)		AST (IU/L)		ALT (IU/L)
	0 day	10th day	0 day	10th day	0 day	10th day	0 day	10th day
Control	38.001 ± 1.447	39.142 ± 1.335	37.002 ± 1.690	42.141 ± 1.565	89.142 ± 2.781	83.431 ± 1.951	40.431 ± 0.812	39.141 ± 0.671
ISP	39.141 ± 2.473	54.712 ± 1.409∗	36.291 ± 2.008	56.431 ± 1.478∗	91.862 ± 1.317	116.122 ± 1.336∗	39.711 ± 0.968	55.862 ± 1.438∗
CFME-LD per se	34.862 ± 1.056	38.001 ± 1.363	37.712 ± 1.426	40.711 ± 0.808	89.291 ± 1.229	83.433 ± 2.487	39.863 ± 0.911	37.143 ± 1.262
CFME-HD per se	38.002 ± 1.345	38.862 ± 1.654	35.292 ± 1.796	41.432 ± 1.798	86.713 ± 1.304	80.863 ± 2.176	40.002 ± 1.113	39.572 ± 1.131
CFME-LD + ISP	37.291 ± 1.835	47.431 ± 2.192	37.001 ± 1.746	49.003 ± 0.6901∗∗	88.433 ± 2.171	107.421 ± 0.948∗∗∗	39.293 ± 1.409	50.143 ± 1.353∗∗∗
CFME-HD + ISP	37.002 ± 1.732	46.431 ± 0.896	36.862 ± 2.334	48.433 ± 1.131∗∗	86.711 ± 1.128	105.325 ± 1.874∗∗	38.715 ± 0.892	48.294 ± 0.993∗∗

ISP: Isoproterenol; CFME-LD: CFME at lower dose (250 mg/kg); CFME-HD: CFME at higher dose (500 mg/kg). Data are expressed as mean value ± S.E.M (n = 7) analyzed using one-way ANOVA followed by Tukey's multiple comparison test. ^∗p < 0.001 when compared to the control group, ^∗∗∗p < 0.05, ^∗∗p < 0.01 when compared to the ISP control group.